Has Ronik Bhangoo received payments from drug or device companies?

Yes. Drug and device makers reported $10,671 in general payments to Ronik Bhangoo across 453 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ronik Bhangoo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ronik Bhangoo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ronik Bhangoo

Radiation Oncology · Mesa, AZNPI 1760877393

Payments from drug & device makers

$10,671in general payments, 2019–2025

Across 453 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$1K
AstraZeneca$907
Daiichi Sankyo Inc.$640
Pfizer$631
Johnson & Johnson$521
Merck$517
plus $6K from 54 others

What the payments were for

Food & beverage$10,635100%
Education$360%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	62	$1,125
AstraZeneca(2 entities)	39	$907
Daiichi Sankyo Inc.	27	$640
Pfizer	31	$631
Johnson & Johnson(2 entities)	27	$521
Merck	26	$517
Eisai Inc.	22	$462
Incyte Corporation	14	$326
Sanofi	12	$267
Boston Scientific	4	$254
Regeneron Healthcare Solutions, Inc.	9	$249
Novocure Inc.	2	$242
Amgen	14	$238
Pharmacosmos Therapeutics Inc.	4	$216
Seagen Inc.	12	$200
Takeda Pharmaceuticals U.S.A., Inc.	8	$195
Genmab U.S., Inc.	7	$192
Tersera Therapeutics LLC	6	$183
Bayer	9	$182
Rigel Pharmaceuticals, Inc.	8	$169
AVEO Pharmaceuticals, Inc.	8	$167
Genentech USA, Inc.	7	$161
AbbVie	7	$161
Exelixis Inc.	3	$156
Blueprint Medicines Corporation	8	$153
Sun Pharmaceutical Industries Inc.	6	$147
Bioprotect Medical, Inc.	1	$138
Teleflex LLC	1	$136
Icotec Medical Inc.	2	$130
Tempus AI, Inc	1	$115
Sumitomo Pharma America, Inc.	4	$103
Beigene USA, Inc.	4	$96
Lilly USA, LLC	4	$94
Ipsen Biopharmaceuticals, Inc	6	$89
GSK	4	$86
Puma Biotechnology, Inc.	3	$81
ADC Therapeutics America, Inc.	4	$80
Carbofix Orthopedics Inc	1	$80
Sobi, Inc	5	$79
E.r. Squibb & Sons, L.L.C.	4	$62
Visionrt, Inc.	1	$59
Karyopharm Therapeutics Inc.	3	$51
G1 Therapeutics, Inc.	3	$50
Coherus Oncology, Inc.	2	$41
Davol Inc.	1	$41
Gilead(2 entities)	2	$39
Iovance Biotherapeutics, Inc.	1	$37
Pharmaessentia USA Corporation	1	$29
Syndax Pharmaceuticals, Inc.	1	$28
Adaptive Biotechnologies Corporation	1	$28
Stemline Therapeutics Inc.	1	$28
Pharmacyclics LLC, An Abbvie Company	1	$28
Legend Biotech USA Inc.	1	$26
Beone Medicines USA, Inc.	1	$26
Bristol Myers Squibb	1	$24
Recordati_rare_diseases_inc.	1	$20
EMD Serono, Inc.	1	$20
Organon	1	$20
Kyowa Kirin, Inc.	1	$18
Taiho Oncology, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,671 in reported general payments places this provider in the 80th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$1,679,851

Medicare patients

368

Services billed

10,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	101	$1,787
Lidocaine Hcl ViscousLidocaine Hcl	24	$509
Dexamethasone	31	$322
Oxycodone Hcl	22	$156

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Mesa

Tam NguyenMesa$12K
Davis RomneyMesa$9K
Chi ZhangScottsdale$495K
Michael GarciaSun City$366K
Michael SamuelsGilbert$323K
John KreslPhoenix$251K
Terence SioScottsdale$221K
Nitika ThawaniPhoenix$199K
Carlos VargasScottsdale$179K
Baldassarre SteaTucson$120K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →